Industry Ventures L.L.C. Invests $386,000 in Notable Labs, Ltd. (NASDAQ:NTBL)

Industry Ventures L.L.C. bought a new position in shares of Notable Labs, Ltd. (NASDAQ:NTBL) during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor bought 204,424 shares of the company’s stock, valued at approximately $386,000. Notable Labs makes up 0.6% of Industry Ventures L.L.C.’s investment portfolio, making the stock its 6th largest position. Industry Ventures L.L.C. owned approximately 9.21% of Notable Labs at the end of the most recent reporting period.

Notable Labs Trading Up 11.2 %

NASDAQ:NTBL traded up $0.12 during trading hours on Wednesday, hitting $1.19. The stock had a trading volume of 205,374 shares, compared to its average volume of 161,253. Notable Labs, Ltd. has a one year low of $0.83 and a one year high of $11.20. The company has a debt-to-equity ratio of 0.02, a quick ratio of 5.65 and a current ratio of 5.65. The company has a market cap of $2.64 million, a price-to-earnings ratio of -0.33 and a beta of 0.93. The business’s 50 day moving average is $1.36 and its 200-day moving average is $1.93.

Analyst Upgrades and Downgrades

NTBL has been the topic of several analyst reports. JMP Securities restated a “market outperform” rating and issued a $9.00 price objective on shares of Notable Labs in a report on Monday, April 15th. Chardan Capital cut their price objective on shares of Notable Labs from $9.00 to $7.00 and set a “buy” rating on the stock in a report on Monday, April 15th.

Notable Labs Company Profile

Notable Labs, Ltd., a clinical-stage platform therapeutics company, engages in developing predictive precision medicines for patients with cancer. The company, through its proprietary Predictive Precision Medicines Platform (PPMP), bio-simulates a cancer treatment and predicts, whether or not the patient is likely to respond to that specific therapeutic.